Viruses 2014, 6(2), 875-892; doi:10.3390/v6020875
Review

CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies

1,2,†email, 1,2,†email, 1,2email, 1,2email, 1,2email, 1,2email and 1,2,3,* email
Received: 3 December 2013; in revised form: 12 February 2014 / Accepted: 13 February 2014 / Published: 18 February 2014
(This article belongs to the Special Issue Viruses and Tetraspanins)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Tetraspanins are integral transmembrane proteins organized in microdomains displaying specific and direct interactions with other tetraspanins and molecular partners. Among them, CD81 has been implicated in a variety of physiological and pathological processes. CD81 also plays a crucial role in pathogen entry into host cells, including hepatitis C virus (HCV) entry into hepatocytes. HCV is a major cause of liver cirrhosis and hepatocellular carcinoma. HCV entry into hepatocytes is a complex process that requires the coordinated interaction of viral and host factors for the initiation of infection, including CD81, scavenger receptor BI, claudin-1, occludin, membrane-bound host cell kinases, Niemann-Pick C1 Like 1, Harvey rat sarcoma viral oncogene homolog (HRas), CD63 and transferrin receptor 1. Furthermore, recent data in HCV model systems have demonstrated that targeting critical components of tetraspanins and associated cell membrane proteins open new avenues to prevent and treat viral infection.
Keywords: antivirals; claudin-1; kinases; liver; transplantation
PDF Full-text Download PDF Full-Text [705 KB, uploaded 18 February 2014 09:43 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Zona, L.; Tawar, R.G.; Zeisel, M.B.; Xiao, F.; Schuster, C.; Lupberger, J.; Baumert, T.F. CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies. Viruses 2014, 6, 875-892.

AMA Style

Zona L, Tawar RG, Zeisel MB, Xiao F, Schuster C, Lupberger J, Baumert TF. CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies. Viruses. 2014; 6(2):875-892.

Chicago/Turabian Style

Zona, Laetitia; Tawar, Rajiv G.; Zeisel, Mirjam B.; Xiao, Fei; Schuster, Catherine; Lupberger, Joachim; Baumert, Thomas F. 2014. "CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies." Viruses 6, no. 2: 875-892.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert